Prevention with icatibant of anaphylactoid reactions to ACE inhibitor during LDL apheresis.
Davidson
D C
DC
Peart
I
I
Turner
S
S
Sangster
M
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000707:Anaphylaxis / Q000517:prevention & control*; D001781:Blood Component Removal; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002216:Captopril / Q000009:adverse effects*; D002648:Child; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000628:therapy*; D008077:Lipoproteins, LDL
D000319:Adrenergic beta-Antagonists; D008077:Lipoproteins, LDL; C065679:icatibant; D002216:Captopril; D001920:Bradykinin